House FDA reform health claims provision "vague and overly broad" -- FDA's Kessler.
This article was originally published in The Tan Sheet
Executive Summary
HOUSE FDA REFORM BILL HEALTH CLAIMS PROVISION "VAGUE AND OVERLY BROAD," FDA Commissioner David Kessler told the House Commerce/health subcommittee at a May 1 hearing. "The bill would appear to allow any information prepared for whatever reason (i.e., not specifically for the purpose of evaluating a diet/disease claim relationship) to form the basis of a health claim," Kessler said.